Serum’s rotavirus vaccine is safe and efficacious
In Phase III trial, Serum Institute’s rotavirus vaccine (ROTASIIL) was found to have nearly 55% efficacy against the very severe form of rotavirus diarrhoea and nearly 39% efficacy in severe…
Category: Serum Institute of India
TB vaccine trial on adults begins in June in India
In June this year, the Pune-based Serum Institute of India Pvt Limited will begin a Phase II/III vaccine trial for tuberculosis using a novel, recombinant BCG (bacillus Calmette-Guérin) vaccine. The…
Why India needs the rubella vaccine?
Buoyed by the successful elimination of polio six years ago and maternal and neonatal tetanus and yaws in 2016, India has set an ambitious target of eliminating measles and controlling…
India’s avoidable rabies burden
Rabies kills nearly 20,000 people in India every year, accounting for a third of global deaths caused due to the disease. The numbers have remained nearly constant for more than…
A step closer to a safer, more efficacious TB vaccine
A potent vaccine against tuberculosis is getting readied at the Pune-based Serum Institute of India Limited. The institute started a ‘Phase 2b’ clinical trial in neonates in South Africa late…
Serum Institute’s H1N1 vaccine will be ready next month
With a sudden spurt in swine flu cases across the country, the Pune-based Serum Institute of India has started the production of its H1N1 vaccine, Nasovac, last month. Nasovac…
Meningitis: Indian vaccine will protect infants also
A meningitis A vaccine (MenAfriVac) manufactured by Serum Institute of India, Pune was approved by WHO a few days ago for use in infants in sub-Saharan African populations. The…
MenAfriVac: first use of vaccine outside of the cold chain in Africa
“It’s a great Indian success story,” said Dr. Jacob John, a former virologist of the Christian Medical College (CMC), Vellore. He was referring to MenAfriVac, a meningitis A vaccine, manufactured…
